# Baxter Oncology GmbH – FDA Inspection, Sep 26, 2025

Source: https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/d2cc3497-33d6-41da-be71-fed681081e29
Source feed: FDA_Inspections

> FDA inspection 1283802 of Baxter Oncology GmbH, September 26, 2025. Classification: Official Action Indicated (OAI). 12 citations under 21 CFR part 211. Form 483 issued. 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1283802
- Company Name: Baxter Oncology GmbH
- Inspection Date: 2025-09-26
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 12

## Related Documents

- [FDA Inspection 1249702 - 2024-08-27](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/8f606d21-cc2a-4cf4-813d-420b7e93dccc)
- [FDA Inspection 1206312 - 2023-05-03](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/49ff9f86-3d55-44a7-abeb-1a0511f483b6)
- FDA Inspection 1161093 - 2020-01-29
- FDA Inspection 1106642 - 2019-09-03
- [FDA Inspection 1056958 - 2018-06-14](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/9da172d1-9118-487f-b26d-5b064e49e5f1)

## Related Officers

- [Investigator](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [FDA Associated Person](https://www.keypedia.com/people/karen-a-briggs/3e77d364-25ea-48c7-87f4-36f3e170bfb5)
- [Investigator](https://www.keypedia.com/people/vivin-george/0b0ee298-a577-4bee-b18e-42da0c3bb148)

Company: https://www.keypedia.com/companies/baxter-oncology-gmbh/43dd5bdb-ca73-4678-ba1f-6ef4b5400e06

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8